- Home
- KRRO vs DHF Comparison
KRRO vs DHF Comparison
Compare KRRO & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- DHF
- Stock Information
- Founded
- KRRO 2014
- DHF 1998
- Country
- KRRO United States
- DHF United States
- Employees
- KRRO N/A
- DHF N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- DHF Finance Companies
- Sector
- KRRO Health Care
- DHF Finance
- Exchange
- KRRO Nasdaq
- DHF Nasdaq
- Market Cap
- KRRO 209.6M
- DHF 172.4M
- IPO Year
- KRRO 2019
- DHF N/A
- Fundamental
- Price
- KRRO $11.42
- DHF $2.51
- Analyst Decision
- KRRO Strong Buy
- DHF
- Analyst Count
- KRRO 7
- DHF 0
- Target Price
- KRRO $85.67
- DHF N/A
- AVG Volume (30 Days)
- KRRO 89.6K
- DHF 451.1K
- Earning Date
- KRRO 05-07-2025
- DHF 01-01-0001
- Dividend Yield
- KRRO N/A
- DHF 7.65%
- EPS Growth
- KRRO N/A
- DHF N/A
- EPS
- KRRO N/A
- DHF N/A
- Revenue
- KRRO $4,821,000.00
- DHF N/A
- Revenue This Year
- KRRO $20.96
- DHF N/A
- Revenue Next Year
- KRRO N/A
- DHF N/A
- P/E Ratio
- KRRO N/A
- DHF N/A
- Revenue Growth
- KRRO N/A
- DHF N/A
- 52 Week Low
- KRRO $11.00
- DHF $2.06
- 52 Week High
- KRRO $98.00
- DHF $2.39
- Technical
- Relative Strength Index (RSI)
- KRRO 34.02
- DHF 56.22
- Support Level
- KRRO $14.54
- DHF $2.45
- Resistance Level
- KRRO $16.68
- DHF $2.54
- Average True Range (ATR)
- KRRO 1.49
- DHF 0.02
- MACD
- KRRO -0.33
- DHF -0.00
- Stochastic Oscillator
- KRRO 6.24
- DHF 57.14
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.